In a groundbreaking development for medical science, the INTERCEPT project has launched Europe’s first biomarker trial aimed at preventing...
Read MoreTris Pharma, Inc. has announced highly encouraging results from its ALLEVIATE-1 phase 3 clinical trial evaluating cebranopadol as a...
Read MoreCambridge Cognition Holdings plc has announced an expansion of its partnership with Actinogen Medical Limited, reinforcing its support for...
Read MoreOxford Drug Design, an innovative drug discovery company based in Oxford, has announced promising new results in the development...
Read MoreProstate cancer that resists hormone therapy could soon have a promising new treatment option. Researchers at the Institute of...
Read MoreThe National Institute for Health and Care Excellence (NICE) has issued a landmark recommendation for the NHS use of...
Read More